Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.

Pharmacogenomics - 1 Sept 2009

Oliveira Elisabete, Pereira Rui, Amorim António, McLeod Howard, Prata Maria João

Abstract excerpt

AIMS: The knowledge that genetic variation influencing drug response is clearly structured among human populations has prompted many studies aimed at obtaining pharmacogenetic profiles in specific populations. While large amounts of data are being produced for populations from developed countries, the African continent still remains very poorly studied. To help to fill this gap, this work characterized three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Africa
Share to Democratic Republic of the Congo

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to History, Ancient

Share to Mozambique

Share to Pharmacogenetics

Share to Population

Share to Portugal

Share to Principal Component Analysis

Source

Identifiers

PMID: 19761365
DOI: 10.2217/pgs.09.74

Genes

ABCB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.PMID 19761365Read ↗

African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug DevelopmentSemantic proximity Read ↗

Pharmacogenomic implications of population admixture: Brazil as a model case.Semantic proximity Read ↗

Cytochrome P450 pharmacogenetics in African populations.Semantic proximity Read ↗

A Review of Clinical Pharmacogenetics Studies in African PopulationsSemantic proximity Read ↗

Population Diversity in Pharmacogenetics: A Latin American Perspective.Semantic proximity Read ↗

Establishment of a biobank and pharmacogenetics database of African populationsSemantic proximity Read ↗

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Semantic proximity Read ↗

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Semantic proximity Read ↗

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global PharmacogeneticsSemantic proximity Read ↗

Polymorphisms of ADME-related genes and their implications for drug safety and efficacy in Amazonian AmerindiansSemantic proximity Read ↗

Pharmacogenomics, ancestry and clinical decision making for global populations.Semantic proximity Read ↗

Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.